Press "Enter" to skip to content

Glenmark Pharma gets tentative USFDA nod for skin treatment drug

Glenmark Pharmaceuticals Inc USA has been granted tentative approval by the United States Food & Drug Administration (USFDA) for Clobetasol Propionate Foam, 0.05 per cent (Emulsion Formulation), the company said in a BSE filing.

Original source: https://health.economictimes.indiatimes.com/news/pharma/glenmark-pharma-gets-tentative-usfda-nod-for-skin-treatment-drug/66804954?utm_source=RSS&utm_medium=ETRSS